Tirofiban | L700462 | Gp IIb/IIIa Receptor Antagonist | AmBeed-信号通路专用抑制剂

首页 / / / 整合素 / Tirofiban

替罗非班 /Tirofiban {[allProObj[0].p_purity_real_show]}

货号：A167431 同义名： L700462;MK383

Tirofiban is a non-peptide reversible antagonist of the platelet integrin glycoprotein (GP) IIb/IIIa receptor used as an antiplatelet drug.

Tirofiban 化学结构
CAS号：144494-65-5

Tirofiban 3D分子结构
CAS号：144494-65-5

规格	价格	会员价	库存	数量
{[ item.pr_size ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]}	{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]}	现货	咨询	- +

购物车0 收藏询单

sales@ambeed.cn tech@ambeed.cn 400-920-2911 产品手册产品订购技术咨询
快速发货顺丰冷链运输，1-2 天到达

品质保证

技术支持

免费溶解

Tirofiban 纯度/质量文件产品仅供科研

货号：A167431 标准纯度： {[allProObj[0].p_purity_real_show]} 产品说明书

批次查询：批次纯度: COA SDS NMR HPLC CNMR LC-MS

全球学术期刊中引用的产品: • Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]; • JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]; • BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]; • J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]; • PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]; 更多 >

整合素亚型比较

产品名称	Integrin ↓ ↑	纯度
Tirofiban	✔	99%+
ATN-161	✔	98%
RGD	✔	98%
A-205804	++ ICAM-1, IC50: 25 nM E-selectin, IC50: 20 nM	98%
SB-273005	++++ αvβ3 receptor, IC50: 1.2 nM αvβ5 receptor, IC50: 0.3 nM	98+%
Lifitegrast	✔	97%
Cilengitide TFA	+++ αvβ3 receptor, IC50: 4.1 nM αvβ5 receptor, IC50: 79 nM	99%+
Cyclo(-RGDfK) TFA	✔	99%+
Cyclo(RGDyK) trifluoroacetate	++ αVβ3 integrin, IC50: 20 nM	99%+
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多，抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用，但抑制强度暂时没有相关数据。

Tirofiban 生物活性

靶点

Integrin

描述

The binding of glycoprotein (GP) IIb/IIIa receptor to fibrinogen is a prerequisite in platelet activation and aggregation. Tirofiban is a potent GPIIb/IIIa antagonist. It inhibited the aggregation of in vitro human gel-filtered platelets induced by ADP, collagen, gamma-thrombin, and U46619 with IC₅₀ values ranging from 12 nM to 31 nM. It also displayed inhibitory activity against human PRP platelet aggregation induced by ADP, collagen, gamma-thrombin, U46619, epinephrine, and arachidonic acid with IC₅₀ values ranging from 31 nM to 66 nM. Tirofiban inhibited the platelet aggregation in human, rhesus monkey, and dog whole blood with IC₅₀ values of 81, 140, and 353 nM, respectively. The intravenous administration of tirofiban (1 mg/kg) in dogs significantly inhibited ex vivo ADP-induced platelet aggregation in platelet-rich plasma (PRP) and the prolongation of template bleeding time. Continuous infusions of tirofiban (0.1-10 µg/kg/min) inhibited ex vivo platelet aggregation in PRP induced by ADP and collagen in a dose-dependent manner. Moreover, the combined treatment with tirofiban (1µg/kg/min, i.v., 120min) and ticlopidine (20 mg/kg/day, p.o., 4 days) in dogs did not change the pharmacokinetic profile of tirofiban nor the platelet count^[3].

Tirofiban 临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
NCT01087723	-		Completed	-	-
NCT01087723	Acute Coronary Syndrome	Phase 3	Completed	-	-
NCT01103440	Stable Angina	Phase 2	Completed	-	United States, New York ... 展开 >> Mount Sinai Medical Center New York, New York, United States, 10029 收起 <<

Tirofiban 参考文献

[1]van 't Hof AW, Valgimigli M. Defining the role of platelet glycoprotein receptor inhibitors in STEMI: focus on tirofiban. Drugs. 2009;69(1):85-100.

[2]Hartman GD, Egbertson MS, et al. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors. J Med Chem. 1992 Nov 27;35(24):4640-2.

[3]Tirofiban (Aggrastat®)

Tirofiban 实验方案

计算器

存储液制备

1mg

5mg

10mg

1 mM

5 mM

10 mM

2.27mL

0.45mL

0.23mL

11.35mL

2.27mL

1.13mL

22.70mL

4.54mL

2.27mL

Tirofiban 技术信息

CAS号	144494-65-5
分子式	C₂₂H₃₆N₂O₅S
分子量	440.597

别名	L700462;MK383
运输	蓝冰

存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,Store in freezer, under -20°C

溶解度

1M HCl: 50 mg/mL(113.48 mM)，配合低频超声，并调节pH至1

动物实验配方

临床研究

NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点

NCT01087723	-		Completed	-	-
NCT01087723	Acute Coronary Syndrome	Phase 3	Completed	-	-
NCT01103440	Stable Angina	Phase 2	Completed	-	United States, New York ... 展开 >> Mount Sinai Medical Center New York, New York, United States, 10029 收起 <<
NCT03691675	Drug-coated Balloon	Not Applicable	Not yet recruiting	April 2019	-
NCT01863134	Non ST Elevation Myocardial In... 展开 >>farction 收起 <<	Phase 4	Completed	-	United States, New York ... 展开 >> Albert Einstein College of Medicine New York, New York, United States Poland First Department of Cardiac Surgery, Medical University of Silesia Katowice, Slaskie, Poland, 40-635 Center for Cardiovascular Research and Development, American Heart of Poland Katowice, Poland Department of Internal Medicine and Clinical Pharmacology Katowice, Poland First Department of Cardiology, Medical University of Silesia Katowice, Poland Division of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College Krakow, Poland 收起 <<
NCT01717573	ST-Elevation Myocardial Infarc... 展开 >>tion 收起 <<	Not Applicable	Completed	-	United Kingdom ... 展开 >> Golden Jubilee National Hospital Clydebank, Glasgow, United Kingdom, G81 4DY 收起 <<
NCT03146858	Primary Percutaneous Coronary ... 展开 >>Intervention 收起 <<	Phase 4	Completed	-	United Kingdom ... 展开 >> Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom, S5 7AU 收起 <<
NCT01863134	-		Completed	-	-
NCT01598337	Coronary Artery Disease	Phase 3	Unknown	-	Saudi Arabia ... 展开 >> Prince Sultan Cardiac Center Recruiting Riyadh, Saudi Arabia Contact: Hussein S Alamri, MD amriheart@hotmail.com Principal Investigator: Antonio Calafiore Principal Investigator: Hussein S Alamri, MD Principal Investigator: Abdulrahman M almoghairi, MD 收起 <<
NCT01103440	-		Completed	-	-
NCT02592720	Acute Coronary Syndromes	Phase 4	Unknown	October 2017	China, Shaanxi ... 展开 >> Xijing hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Dongdong Sun, M.D.,Ph.D 86 18691569930 wintersun3@gmail.com 收起 <<
NCT01433627	Acute Coronary Syndromes ... 展开 >> STEMI NSTEMI 收起 <<	Phase 3	Unknown	December 2015	-
NCT03078257	Coronary Artery Disease	Phase 1	Recruiting	December 2017	China, Jiangsu ... 展开 >> First Affiliated Hospital of Nanjing Medical University Recruiting Nanjing, Jiangsu, China, 210029 Contact: Fuming Zhang, M.D. +86-25-83718836 ext 6360 jsphkj@163.com Contact: Yi Chai, M.D. +86-25-83718836 ext 6360 jsphkj@163.com Sub-Investigator: Dingguo Zhang, Ph.D 收起 <<
NCT00713557	-		Terminated(devices applied in ... 展开 >>the study were no more available in the market, and medical intervention section was completed.) 收起 <<	-	China, Shanghai ... 展开 >> Dept. of Cardiology, Ruijin Hospital Shanghai, Shanghai, China, 200025 收起 <<
NCT00251576	Acute Coronary Syndrome	Phase 3	Completed	-	-
NCT00445263	CORONARY DISEASE	Phase 4	Terminated(Because of inclusio... 展开 >>n delay) 收起 <<	-	France ... 展开 >> Samu 93 - Chu Avicenne Bobigny, Ile de France, France, 93000 收起 <<
NCT03406819	ST Segment Elevation Myocardia... 展开 >>l Infarction Primary Percutaneous Coronary Intervention 收起 <<	Not Applicable	Recruiting	December 31, 2019	China, Henan ... 展开 >> Anyang District Hospital Recruiting Anyang, Henan, China, 455000 The 99th Central Hospital of the People's Liberation Army Recruiting Jiaozuo, Henan, China, 454000 The People's Hospital of Jiaozuo Recruiting Jiaozuo, Henan, China, 454002 The second people's Hospital of Jiyuan Recruiting Jiyuan, Henan, China, 454000 Huaihe Hospital of Henan University Recruiting Kaifeng, Henan, China, 475000 Kaifeng Central Hospital Recruiting Kaifeng, Henan, China, 475000 The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Lushan People's Hospital Recruiting Lushan, Henan, China, 467300 Nanyang City Center Hospital Recruiting Nanyang, Henan, China, 473000 Pingmei Shenma Medical Group General Hospital Recruiting Pingdingshan, Henan, China, 467000 The Second People's Hospital of Pingdingshan Recruiting Pingdingshan, Henan, China, 467000 Puyang Oilfield General Hospital Recruiting Puyang, Henan, China, 457000 Puyang People's Hospital Recruiting Puyang, Henan, China, 457099 Yellow River Sanmenxia hospital Recruiting Sanmenxia, Henan, China, 472000 The First People's Hospital of Shangqiu Recruiting Shangqiu, Henan, China, 476000 The First Affiliated Hospital of Xinxiang Medical University Recruiting Xinxiang, Henan, China, 453100 Xinyang Central Hospital Recruiting Xinyang, Henan, China, 464000 Yanshi People's Hospital Recruiting Yanshi, Henan, China, 471900 Zhengzhou First People's Hospital Recruiting Zhengzhou, Henan, China, 450004 Zhengzhou Cardiovascular Hospital Recruiting Zhengzhou, Henan, China, 450006 Zhengzhou Central Hospital Recruiting Zhengzhou, Henan, China, 450007 The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Chunguang Qiu, Phd People's Hospital of Zhengzhou Recruiting Zhengzhou, Henan, China, 450053 The First People's Hospital of Xinmi Recruiting Zhengzhou, Henan, China, 452370 Zhoukou Central Hospital Recruiting Zhoukou, Henan, China, 466000 The First People's Hospital of Zhumadian Recruiting Zhumadian, Henan, China, 463000 Zhumadian Central Hospital Recruiting Zhumadian, Henan, China, 463000 China, Shanxi Jincheng People's Hospital Recruiting Jincheng, Shanxi, China, 048026 收起 <<
NCT00653601	-		Unknown	April 2011	United States, California ... 展开 >> Cedars-Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Sanjay Kaul, MD 310-423-4876 sanjay.kaul@cshs.org Contact: Suhail Dohad, MD 310-278-3400 dohad@cvmg.com Principal Investigator: Sanjay Kaul, MD Sub-Investigator: Amanda B Lamer, PharmD Sub-Investigator: Hai Tran, PharmD Sub-Investigator: Stanley Chou, MD Sub-Investigator: Suhail Dohad, MD 收起 <<
NCT03406832	ST Segment Elevation Myocardia... 展开 >>l Infarction Elective Percutaneous Coronary Intervention 收起 <<	Not Applicable	Recruiting	December 31, 2019	China, Henan ... 展开 >> Anyang District Hospital Recruiting Anyang, Henan, China, 455000 The 99th Central Hospital of the People's Liberation Army Recruiting Jiaozuo, Henan, China, 454000 The People's Hospital of Jiaozuo Recruiting Jiaozuo, Henan, China, 454002 The second people's Hospital of Jiyuan Recruiting Jiyuan, Henan, China, 454000 Huaihe Hospital of Henan University Recruiting Kaifeng, Henan, China, 475000 Kaifeng Central Hospital Recruiting Kaifeng, Henan, China, 475000 The First Affiliated Hospital of Henan University of Science and Technology Recruiting Luoyang, Henan, China, 471003 Lushan People's Hospital Recruiting Lushan, Henan, China, 467300 Nanyang City Center Hospital Recruiting Nanyang, Henan, China, 473000 Pingmei Shenma Medical Group General Hospital Recruiting Pingdingshan, Henan, China, 467000 The Second People's Hospital of Pingdingshan Recruiting Pingdingshan, Henan, China, 467000 Puyang Oilfield General Hospital Recruiting Puyang, Henan, China, 457000 Puyang People's Hospital Recruiting Puyang, Henan, China, 457099 Yellow River Sanmenxia hospital Recruiting Sanmenxia, Henan, China, 472000 The First People's Hospital of Shangqiu Recruiting Shangqiu, Henan, China, 476000 The First Affiliated Hospital of Xinxiang Medical University Recruiting Xinxiang, Henan, China, 453100 Xinyang Central Hospital Recruiting Xinyang, Henan, China, 464000 Yanshi People's Hospital Recruiting Yanshi, Henan, China, 471900 Zhengzhou First People's Hospital Recruiting Zhengzhou, Henan, China, 450004 Zhengzhou Cardiovascular Hospital Recruiting Zhengzhou, Henan, China, 450006 Zhengzhou Central Hospital Recruiting Zhengzhou, Henan, China, 450007 The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Chunguang Qiu, Phd People's Hospital of Zhengzhou Recruiting Zhengzhou, Henan, China, 450053 The First People's Hospital of Xinmi Recruiting Zhengzhou, Henan, China, 452370 Zhoukou Central Hospital Recruiting Zhoukou, Henan, China, 466000 The First People's Hospital of Zhumadian Recruiting Zhumadian, Henan, China, 463000 Zhumadian Central Hospital Recruiting Zhumadian, Henan, China, 463000 China, Shanxi Jincheng People's Hospital Recruiting Jincheng, Shanxi, China, 048026 收起 <<
NCT01696110	Acute Myocardial Infarction ... 展开 >> Percutaneous Coronary Intervention 收起 <<	Phase 4	Completed	-	-
NCT00300833	Acute Myocardial Infarction	Phase 4	Unknown	-	Israel ... 展开 >> Cardiovascular Division, The Baruch Padeh Medical Center, Poriya, Recruiting Tiberias, Israel, 15208 Magen David , Recruiting Tiberias, Israel Contact: Sergay Krablikov, Dr 收起 <<
NCT03691727	Subarachnoid Hemorrhage, Aneur... 展开 >>ysmal 收起 <<	Phase 1 Phase 2	Not yet recruiting	November 2022	-
NCT00611169	Acute Myocardial Infarction	Phase 4	Completed	-	-
NCT00445263	-		Terminated(Because of inclusio... 展开 >>n delay) 收起 <<	-	-
NCT00229515	Myocardial Infarction	Phase 4	Unknown	March 2012	Italy ... 展开 >> Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara Ferrara, Italy, 44100 收起 <<
NCT00538317	Acute Myocardial Infarction	Phase 4	Completed	-	France ... 展开 >> Hospices Civils de Lyon Lyon, France, 6900 收起 <<
NCT00306228	Myocardial Infarction	Phase 4	Completed	-	Spain ... 展开 >> Instituto de Ciencias del Corazón (ICICOR). Hospital Clínico Universitario de Valladolid Valladolid, Spain, 47005 收起 <<
NCT00790387	Acute Coronary Syndrome	Phase 4	Completed	-	Australia, Queensland ... 展开 >> The Prince Charles Hospital Brisbane, Queensland, Australia, 4032 收起 <<
NCT02131220	Myocardial Infarction ... 展开 >> Percutaneous Coronary Intervention Thrombolytic Therapy 收起 <<	Phase 4	Completed	-	China, Shanghai ... 展开 >> Department of Cardiology, Zhongshan Hospital, Fudan University Shanghai, Shanghai, China, 200032 收起 <<
NCT01336348	ST Segment Elevation Myocardia... 展开 >>l Infarction 收起 <<	Phase 3	Completed	-	Italy ... 展开 >> Cardiology Unit Ferrara, Italy, 44100 收起 <<
NCT01660373	Non-ST Segment Elevation Acute... 展开 >> Coronary Syndrome 收起 <<	Phase 3	Unknown	August 2013	Korea, Republic of ... 展开 >> Pusan National University Yangsan Hospital Recruiting Yangsan, Kyeongsangnamdo, Korea, Republic of, 626-770 Contact: June Hong Kim, MD, PhD +82-10-8231-7171 junehongk@gmail.com Contact: Dongcheul Han, MD +82-10-2992-6270 usdoc12@gmail.com Principal Investigator: June Hong Kim, MD,PhD Sub-Investigator: Dongcheul Han, MD 收起 <<
NCT00383136	Acute Myocardial Infarction	Phase 4	Completed	-	Italy ... 展开 >> Divisione Di Cardiologia, Ospedale Maggiore Bologna, BO, Italy, 40100 Laboratorio Di Emodinamica, Istituto Di Cardiologia, Azienda Ospedaliera S.Orsola Malpighi Bologna, BO, Italy, 40138 Azienda Ospedaliera Universitaria Policlinico Modena, MO, Italy, 41100 Divisione Di Cardiologia, Ospedale S.Maria Nuova Reggio Emilia, RE, Italy, 42100 Divisione Di Cardiologia, Ospedale Per Gli Infermi Rimini, RN, Italy, 47900 Divisione Di Cardiologia Ii, Ospedale Policlinico Le Molinette Torino, TO, Italy, 10100 收起 <<
NCT00398463	Angioplasty, Transluminal, Per... 展开 >>cutaneous Coronary 收起 <<	Phase 4	Completed	-	Italy ... 展开 >> Cattedra di Cardiologia, Azienda Ospedaliera Universitaria di Ferrara Ferrara, Fe, Italy, 44100 收起 <<
NCT01522417	Myocardial Infarction ... 展开 >> Acute Coronary Syndromes Unstable Angina 收起 <<	Phase 2	Recruiting	July 2019	United States, Florida ... 展开 >> Osceola Regional Medical Center Completed Kissimmee, Florida, United States, 34741 Northside Hospital Completed Saint Petersburg, Florida, United States, 33709 United States, Georgia Emory University Hospital Midtown Completed Atlanta, Georgia, United States, 30308 Emory University Hospital Completed Atlanta, Georgia, United States, 30322 North Georgia Heart Center Completed Gainesville, Georgia, United States, 30501 Redmond Regional Medical Center Recruiting Rome, Georgia, United States, 30165 Principal Investigator: Hector R Picon, MD Archbold Medical Center Completed Thomasville, Georgia, United States, 31792 United States, New York Lenox Hill Hospital Completed New York, New York, United States, 10075 United States, Oklahoma University of Oklahoma Health Sciences Center Recruiting Oklahoma City, Oklahoma, United States, 73104 Principal Investigator: Mazen Abu-Fadel, MD United States, Pennsylvania Doylestown Hospital Completed Doylestown, Pennsylvania, United States, 18901 Penn Presbyterian Medical Center Completed Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Centennial Heart Recruiting Nashville, Tennessee, United States, 37203 Principal Investigator: Brian K Jefferson, MD United States, Virginia Chippenham Hospital Recruiting Richmond, Virginia, United States, 23225 Principal Investigator: Michael L Arcarese, MD 收起 <<
NCT01498003	Coronary Artery Disease	Phase 4	Completed	-	China, Shanghai ... 展开 >> Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, Shanghai, China, 200025 收起 <<
NCT01245725	Myocardial Infarction ... 展开 >> Acute Coronary Syndromes Unstable Angina Percutaneous Coronary Intervention 收起 <<	Phase 3	Withdrawn(Study was not initia... 展开 >>ted, change in clinical development) 收起 <<	-	-
NCT02978040	Coronary Artery Disease ... 展开 >> STEMI - ST Elevation Myocardial Infarction 收起 <<	Phase 4	Recruiting	April 2019	France ... 展开 >> Group Hospitalier Pitié-Salpetrière Not yet recruiting Paris, France, 75013 Contact: Jean-Philippe Collet, Prof jean-philippe.collet@aphp.fr Italy University of Ferrara Not yet recruiting Ferrara, Italy, 44124 Contact: Gianluca Campo, Prof cmpglc@unife.it University of Naples Federico II Recruiting Naples, Italy, 80131 Contact: Giovanni Esposito, Prof espogiov@unina.it University of Sassari Not yet recruiting Sassari, Italy, 07100 Contact: Guido Parodi, Prof parodiguido@gmail.com Principal Investigator: Pierfranco Terrosu, MD Switzerland Bern University Hospital Recruiting Bern, Switzerland, 3010 Contact: Marco Valgimigli, Prof +41 316329653 marco.valgimigli@insel.ch Contact: Giuseppe Gargiulo, MD +41 316327205 giuseppe.gargiulo@insel.ch 收起 <<
NCT00566891	Coronary Artery Disease	Phase 4	Completed	-	Italy ... 展开 >> S Anna Hospital Catanzaro, Italy, 88100 收起 <<
NCT00407771	Coronary Artery Disease	Phase 4	Unknown	December 2008	Jordan ... 展开 >> Jordan Hospital Not yet recruiting Amman, Jordan, 11152 Principal Investigator: Imad A Alhaddad, MD 收起 <<
NCT03357133	Ischemic Stroke	Phase 2 Phase 3	Recruiting	March 31, 2019	China, An Hui ... 展开 >> Suzhou Municipal Hoapital Recruiting Suzhou, An Hui, China Contact: Zhengfei Ma, MD China, Beijing Xuanwu Hospital, Capital Medical University Recruiting Beijing, Beijing, China, 100053 Contact: Xunming Ji Principal Investigator: Xunming Ji China, Henan The Central Hospital of Luohe City Recruiting Luohe, Henan, China Contact: Shengming Huang, MD hsm912@126.com China, Sichuan Luzhou People's Hospital Recruiting Luzhou, Sichuan, China Contact: Li Zhou, MD China Xiangtan Central Hospital Recruiting Xiangtan, China Contact: Yong Liang The Fifth Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, China Contact: Lijun Wang The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, China Contact: Yajun Lian 收起 <<
NCT01181388	Myocardial Infarction	Not Applicable	Unknown	October 2012	China, Beijing ... 展开 >> the 28th division, Beijing Anzhen Hospital Recruiting Beijing, Beijing, China, 100029 Contact: Shaoping Shaoping, MD. PhD +861064456995 wang_shaoping@hotmail.com Contact: Yunpeng Chi, MD +861064456541 chiyunpeng0711@sohu.com 收起 <<
NCT01109134	Acute Myocardial Infarction	Phase 3	Completed	-	-
NCT03048019	-		Recruiting	May 29, 2019	United States, Virginia ... 展开 >> Inova Health Care System Recruiting Falls Church, Virginia, United States, 22042 Contact: Kevin Bliden, BS, MBA 703-776-7702 kevin.bliden@inova.org 收起 <<
NCT03114995	-		Completed	-	-
NCT02592694	ST-elevation Myocardial Infarc... 展开 >>tion 收起 <<	Phase 4	Unknown	October 2017	China, Shaanxi ... 展开 >> Xijing hospital Recruiting Xi'an, Shaanxi, China, 710032 Contact: Dongdong Sun, M.D.,Ph.D 86 18691569930 wintersun3@gmail.com 收起 <<
NCT01766154	Renal Insufficiency	Phase 1	Completed	-	United States, Florida ... 展开 >> Avail Clinical Research, LLC DeLand, Florida, United States, 32720 收起 <<
NCT02054000	No-Reflow Phenomenon	Phase 4	Completed	-	Turkey ... 展开 >> Erciyes University School of Medicine Kayseri, Turkey, 38039 收起 <<
NCT03114995	Non-ST Elevation Myocardial In... 展开 >>farction 收起 <<	Phase 4	Completed	-	-
NCT02294994	Coronary Artery Disease	Phase 4	Unknown	December 2016	China, Jilin ... 展开 >> The sencond hospital of Jilin University Recruiting Changchun, Jilin, China, 130041 Contact: Liu Bin, M.D. +86 13500810268 liubin3333@vip.sina.com 收起 <<

替罗非班 /Tirofiban {[allProObj[0].p_purity_real_show]}

Tirofiban 纯度/质量文件产品仅供科研

全球学术期刊中引用的产品

Tirofiban 质控信息

Tirofiban 生物活性

Tirofiban 临床研究

Tirofiban 参考文献

Tirofiban 实验方案

Tirofiban 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

替罗非班 /Tirofiban {[allProObj[0].p_purity_real_show]}

Tirofiban 纯度/质量文件 产品仅供科研

全球学术期刊中引用的产品

Tirofiban 质控信息

Tirofiban 生物活性

Tirofiban 临床研究

Tirofiban 参考文献

Tirofiban 实验方案

Tirofiban 技术信息

最近浏览的产品

大规格询价

摩尔计算器

靶点

总药量计算器

工作液计算器

细胞研究

临床研究

确认信息

请登录您的专属账户

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

Tirofiban 纯度/质量文件产品仅供科研